The glucose lowering drug is being tested in a trial that will enroll 72 healthy volunteers.
"This is our sixth entity to enter the clinic and bears testimony to our efforts to build a diversified and strong pipeline of products to address unmet medical needs," said Dr Somesh Sharma, managing director, Piramal Life Sciences.
The drug discovery process involves 10-15 years of research and Phase I-III clinical trials.
